An der Goldgrube 12
March 31, 2020
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-3561
Attn: Paul Fischer
Registration Statement on Form F-4
Filed March 31, 2020
|File No. 333-237515|
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the Securities Act), BioNTech SE (the Company) hereby respectfully requests that the effective date of the above-referenced Registration Statement on Form F-4 (the Registration Statement) be accelerated by the U.S. Securities and Exchange Commission so that the Registration Statement will be declared effective under the Securities Act at 4:00 p.m. Eastern Time on April 2, 2020, or as soon thereafter as is practicable, or such other time as the Company or its counsel, Covington & Burling LLP, may request by telephone that such Registration Statement be declared effective.
We respectfully request that we be notified of such effectiveness by a telephone call to Brian K. Rosenzweig of Covington & Burling LLP at (212) 841-1108 and that such effectiveness also be confirmed in writing.
|Name:||Prof. Ugur Sahin, M.D.|
Chief Executive Officer
Brian K. Rosenzweig, Covington & Burling LLP